170 related articles for article (PubMed ID: 13680329)
1. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome?
Alshaya HO; Al-Maghrabi JA; Kari JA
Pediatr Nephrol; 2003 Nov; 18(11):1143-6. PubMed ID: 13680329
[TBL] [Abstract][Full Text] [Related]
2. Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease.
Haddad M; Kale A; Butani L
BMC Nephrol; 2021 Nov; 22(1):395. PubMed ID: 34839817
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
4. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.
Mori K; Honda M; Ikeda M
Pediatr Nephrol; 2004 Nov; 19(11):1232-6. PubMed ID: 15322892
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
[TBL] [Abstract][Full Text] [Related]
7. Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.
Elhence R; Gulati S; Kher V; Gupta A; Sharma RK
Pediatr Nephrol; 1994 Feb; 8(1):1-3. PubMed ID: 8142205
[TBL] [Abstract][Full Text] [Related]
8. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
9. Treatment of steroid resistant nephrotic syndrome in children.
Kari JA; Halawani M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
[TBL] [Abstract][Full Text] [Related]
10. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
Kari JA; Halawani M; Mokhtar G; Jalalah SM; Anshasi W
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):854-7. PubMed ID: 19736491
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
12. Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria.
Olowu WA; Adelusola KA; Adefehinti O
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):979-90. PubMed ID: 20814150
[TBL] [Abstract][Full Text] [Related]
13. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
[TBL] [Abstract][Full Text] [Related]
14. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
15. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
[TBL] [Abstract][Full Text] [Related]
16. Steroid resistant nephrotic syndrome: role of histopathology.
Gulati S; Sengupta D; Sharma RK; Sharma A; Gupta RK; Singh U; Gupta A
Indian Pediatr; 2006 Jan; 43(1):55-60. PubMed ID: 16465008
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
18. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
